![James Ford](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
James Ford
Director Ejecutivo en
Metuchen Pharmaceuticals LLC
.
Perfil
James Gregory Ford currently works at Metuchen Pharmaceuticals LLC, as President & Chief Executive Officer.
Mr. Ford also formerly worked at Petros Pharmaceuticals, Inc., as Chief Executive Officer, Boehringer Ingelheim Pharmaceuticals, Inc., as Associate Director-Business Development from 1997 to 1999, CollaGenex Pharmaceuticals, Inc., as VP-Business Development & Strategic Planning from 2004 to 2008, PolyMedix, Inc., as Vice President-Business Development, SkyePharma Canada, Inc., as President & Chief Operating Officer from 1999 to 2004, and Pacira Pharmaceuticals, Inc. (California), as Vice President-Global Business Development.
Mr. Ford received his undergraduate degree and Masters Business Admin degree from West Virginia University.
Cargos activos de James Ford
| Empresas | Cargo | Inicio |
|---|---|---|
Metuchen Pharmaceuticals LLC
 Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Director Ejecutivo | - |
Antiguos cargos conocidos de James Ford.
| Empresas | Cargo | Fin |
|---|---|---|
| PETROS PHARMACEUTICALS, INC. | Director Ejecutivo | 04/07/2020 |
CollaGenex Pharmaceuticals, Inc.
 CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Corporate Officer/Principal | 10/04/2008 |
Pacira Pharmaceuticals, Inc. (California)
 Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Corporate Officer/Principal | - |
SkyePharma Canada, Inc.
 SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Improves the solubility of drugs via nano-particulate technology | Presidente | 01/01/2004 |
Boehringer Ingelheim Pharmaceuticals, Inc.
 Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Corporate Officer/Principal | 01/01/1999 |
Formación de James Ford.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
25
Relaciones de 1er grado
8
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 8 |
|---|---|
CollaGenex Pharmaceuticals, Inc.
CollaGenex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops and markets medical therapies to the dental & dermatology market | Health Technology |
PolyMedix, Inc.
 PolyMedix, Inc. Pharmaceuticals: MajorHealth Technology Develops synthetic small molecule compound drugs | Health Technology |
SkyePharma Canada, Inc.
SkyePharma Canada, Inc. Miscellaneous Commercial ServicesCommercial Services Improves the solubility of drugs via nano-particulate technology | Commercial Services |
West Virginia University
 West Virginia University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Pacira Pharmaceuticals, Inc. (California)
Pacira Pharmaceuticals, Inc. (California) Medical SpecialtiesHealth Technology Develops and manufactures injectable and sustained release therapeutic products | Health Technology |
Boehringer Ingelheim Pharmaceuticals, Inc.
Boehringer Ingelheim Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
Metuchen Pharmaceuticals LLC
Metuchen Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Manufactures and markets pharmaceutical products | Health Technology |
Petros Pharmaceuticals, Inc.
 Petros Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufacturers and distributes pharmaceutical products | Health Technology |
- Bolsa de valores
- Insiders
- James Ford
